{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:03:47Z","timestamp":1790046227990,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijrobp.2020.03.040","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T01:53:20Z","timestamp":1586742800000},"page":"793-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas"],"prefix":"10.1016","volume":"107","author":[{"given":"Michael M.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopika","family":"SenthilKumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saakshi","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangok P.","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Kimple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Baschnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.03.040_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40291-016-0204-5","article-title":"FGFR family members protein expression as prognostic markers in oral cavity and oropharyngeal squamous cell carcinoma","volume":"20","author":"Koole","year":"2016","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.2013.58","article-title":"Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck","volume":"26","author":"Goke","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.oraloncology.2006.01.005","article-title":"Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC)","volume":"43","author":"Freier","year":"2007","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib8","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1158\/1078-0432.CCR-15-1874","article-title":"FGFR1 is a potential prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma","volume":"22","author":"Koole","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib9","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1158\/1078-0432.CCR-15-2785","article-title":"Proteomic profiling identifies PTK2\/FAK as a driver of radioresistance in HPV-negative head and neck cancer","volume":"22","author":"Skinner","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib10","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/1078-0432.CCR-11-0050","article-title":"Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells","volume":"17","author":"Marshall","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib11","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.oraloncology.2012.06.011","article-title":"Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts","volume":"48","author":"Sweeny","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1158\/0008-5472.CAN-11-3034","article-title":"AZD4547: An orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family","volume":"72","author":"Gavine","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/1078-0432.CCR-12-2746","article-title":"Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts","volume":"19","author":"Kimple","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib14","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib15","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.oraloncology.2016.11.017","article-title":"Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts","volume":"64","author":"Swick","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib18","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-14-3357","article-title":"FGFR1 expression levels predict BGJ398 densitivity of FGFR1-dependent head and neck squamous cell cancers","volume":"21","author":"Goke","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/bjc.2013.550","article-title":"The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1","volume":"109","author":"Nguyen","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/mol.112.084111","volume":"83","author":"Singleton","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib21","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ejca.2014.05.012","article-title":"Preclinical evidence that SSR128129E\u2014a novel small-molecule multi-fibroblast growth factor receptor blocker\u2014radiosensitises human glioblastoma","volume":"50","author":"Ader","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib22","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1038\/sj.onc.1205746","article-title":"RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death","volume":"21","author":"Ader","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/ijc.22561","article-title":"Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells","volume":"120","author":"Ishigami","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib24","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1038\/onc.2011.159","article-title":"Targeting fibroblast growth factor receptor 3 enhances radiosensitivity in human squamous cancer cells","volume":"30","author":"Uzawa","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib25","first-page":"1364","article-title":"Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells","volume":"57","author":"Cohen-Jonathan","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib26","first-page":"2582","article-title":"Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in\u00a0vitro and in\u00a0vivo","volume":"54","author":"Fuks","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib27","first-page":"2591","article-title":"Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis","volume":"54","author":"Haimovitz-Friedman","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib28","first-page":"G249","article-title":"FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury","volume":"276","author":"Houchen","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2009.11.026","article-title":"Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation","volume":"77","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccell.2019.01.020","article-title":"Inhibition of nuclear PTEN tyrosine phosphorylation enhances glioma radiation sensitivity through attenuated DNA repair","volume":"35","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib31","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/annonc\/mdx107","article-title":"A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification","volume":"28","author":"Van Cutsem","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib32","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1158\/1078-0432.CCR-17-0645","article-title":"A phase Ib open-label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers","volume":"23","author":"Paik","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10637-016-0416-x","article-title":"Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: A Phase I study","volume":"35","author":"Saka","year":"2017","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib34","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jtho.2019.05.041","article-title":"SWOG S1400D (NCT02965378), a phase II study of the fibroblast growth factor receptor inhibitor AZD4547 in previously treated patients with fibroblast growth factor pathway-activated stage IV squamous cell lung cancer (lung-MAP substudy)","volume":"14","author":"Aggarwal","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib35","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/2159-8290.CD-15-1246","article-title":"High-level clonal FGFR amplification and response to FGFR inhibition in a translational clinical trial","volume":"6","author":"Pearson","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib36","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/1078-0432.CCR-13-3060","article-title":"FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies","volume":"20","author":"Wynes","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib37","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1158\/0008-5472.CAN-18-0757","article-title":"Transcriptomics and transposon mutagenesis identify multiple mechanisms of resistance to the FGFR inhibitor AZD4547","volume":"78","author":"Kas","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib38","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1158\/0008-5472.CAN-15-0509","article-title":"Kinome RNAi screens reveal synergistic targeting of MTOR and FGFR1 pathways for treatment of lung cancer and HNSCC","volume":"75","author":"Singleton","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib39","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.radonc.2016.02.028","article-title":"To live or let die: Unclear task of autophagy in the radiosensitization battle","volume":"119","author":"Ondrej","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.03.040_bib41","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/2326-6066.CIR-18-0595","article-title":"The combined effect of FGFR inhibition and PD-1 blockade promotes tumor-intrinsic induction of antitumor immunity","volume":"7","author":"Palakurthi","year":"2019","journal-title":"Cancer Immunol Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620309846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620309846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:47:18Z","timestamp":1759744038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620309846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0360301620309846"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.03.040","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}